HK1070921A1 - Method for determining the expression level of glutathione-s-transferase pi - Google Patents

Method for determining the expression level of glutathione-s-transferase pi

Info

Publication number
HK1070921A1
HK1070921A1 HK05103515.5A HK05103515A HK1070921A1 HK 1070921 A1 HK1070921 A1 HK 1070921A1 HK 05103515 A HK05103515 A HK 05103515A HK 1070921 A1 HK1070921 A1 HK 1070921A1
Authority
HK
Hong Kong
Prior art keywords
gst
expression level
mrna
patient
glutathione
Prior art date
Application number
HK05103515.5A
Other languages
English (en)
Inventor
Kathleen D Danenberg
Original Assignee
Response Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Response Genetics Inc filed Critical Response Genetics Inc
Publication of HK1070921A1 publication Critical patent/HK1070921A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/01018—Glutathione transferase (2.5.1.18)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK05103515.5A 2001-06-14 2005-04-25 Method for determining the expression level of glutathione-s-transferase pi HK1070921A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/879,986 US6686155B2 (en) 2001-06-14 2001-06-14 Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
PCT/US2002/015203 WO2002103055A1 (en) 2001-06-14 2002-05-15 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION

Publications (1)

Publication Number Publication Date
HK1070921A1 true HK1070921A1 (en) 2005-06-30

Family

ID=25375288

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05103515.5A HK1070921A1 (en) 2001-06-14 2005-04-25 Method for determining the expression level of glutathione-s-transferase pi

Country Status (15)

Country Link
US (4) US6686155B2 (zh)
EP (1) EP1407047B1 (zh)
JP (2) JP4303104B2 (zh)
KR (2) KR20090060380A (zh)
CN (2) CN100494398C (zh)
AR (1) AR034342A1 (zh)
AU (1) AU2002305573B2 (zh)
CA (1) CA2450257C (zh)
ES (1) ES2457077T3 (zh)
HK (1) HK1070921A1 (zh)
IL (2) IL159301A0 (zh)
MX (1) MXPA03011632A (zh)
NZ (1) NZ530520A (zh)
TW (1) TWI338049B (zh)
WO (1) WO2002103055A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
US7871769B2 (en) * 2004-04-09 2011-01-18 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
US20060115827A1 (en) * 2004-07-01 2006-06-01 University Of Southern California Genetic markers for predicting disease and treatment outcome
EP2204454A1 (en) * 2005-05-04 2010-07-07 University of South Florida Predicting treatment response in cancer subjects
US20070059753A1 (en) * 2005-09-15 2007-03-15 Tatiana Vener Detecting gene methylation
AU2008266048A1 (en) * 2007-06-15 2008-12-24 University Of South Florida Methods of diagnosing and treating cancer
AU2009339802B2 (en) * 2009-02-16 2014-07-24 Atlas Antibodies Ab RBM3 as a marker for malignant melanoma prognosis
JP5361488B2 (ja) 2009-03-24 2013-12-04 オリンパス株式会社 蛍光観察装置
JP5680442B2 (ja) * 2011-02-24 2015-03-04 シスメックス株式会社 癌細胞のタキサン系抗癌剤感受性判定方法、それを実現するためのコンピュータプログラム及び装置
GB201316027D0 (en) * 2013-09-09 2013-10-23 Almac Diagnostics Ltd Molecular diagnostic test for oesophageal cancer
WO2016104588A1 (ja) * 2014-12-26 2016-06-30 日東電工株式会社 細胞死誘導剤、細胞増殖抑制剤及び細胞の増殖異常に起因する疾患の治療用医薬組成物
CN112321489B (zh) * 2020-10-15 2022-04-19 中山大学 一种基于活性巯基和报告离子的亲电分子探针及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830969A (en) 1981-08-31 1989-05-16 The Research Foundation Of State University Of New York Process for the rapid and simple isolation of nucleic acids
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5128247A (en) * 1989-08-14 1992-07-07 Board Of Regents, The University Of Texas System Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources
US5942389A (en) * 1990-10-19 1999-08-24 Board Of Trustees Of The University Of Illinois Genes and genetic elements associated with sensitivity to cisplatin
US5204241A (en) * 1990-10-22 1993-04-20 Oxi-Gene Inc. Glutathione-S-transferase mu as a measure of drug resistance
US5654179A (en) * 1990-11-14 1997-08-05 Hri Research, Inc. Nucleic acid preparation methods
US5284940A (en) 1990-11-14 1994-02-08 Hri Research, Inc. Preparation for nucleic acid samples
US5620852A (en) 1990-11-14 1997-04-15 Hri Research, Inc. Nucleic acid preparation methods
US5346994A (en) 1992-01-28 1994-09-13 Piotr Chomczynski Shelf-stable product and process for isolating RNA, DNA and proteins
US5502166A (en) * 1992-02-26 1996-03-26 Mitsubishi Chemical Corporation NMDH receptor proteins and genes encoding the same
AU6230594A (en) * 1993-02-01 1994-08-29 University Of Iowa Research Foundation, The Quartenary amine surfactants and methods of using same in isolation of rna
US5637687A (en) * 1993-08-31 1997-06-10 Wiggins; James C. Methods and compositions for isolating nucleic acids
WO1995028489A1 (en) 1994-04-13 1995-10-26 The Uab Research Foundation Dihydropyrimidine dehydrogenase compositions and methods of use
US5643767A (en) 1994-05-02 1997-07-01 The Rockefeller University Process for isolating cellular components
CA2153215A1 (en) * 1994-07-06 1996-01-07 Lu Wang Treatment of paraffin embedded tissue for gene analysis
US6136605A (en) * 1994-08-26 2000-10-24 Wisconsin Alumni Research Foundation Glutathione S-transferase isoforms
US5707802A (en) 1995-01-13 1998-01-13 Ciba Corning Diagnostics Corp. Nucleic acid probes for the detection and identification of fungi
US5777099A (en) 1995-02-24 1998-07-07 Biotecx Laboratories, Inc. RNA separation
US5945515A (en) 1995-07-31 1999-08-31 Chomczynski; Piotr Product and process for isolating DNA, RNA and proteins
DE29601618U1 (de) * 1996-01-31 1996-07-04 Invitek Gmbh Vorrichtung zur gleichzeitigen multiplen Isolierung
EP0791654A1 (en) * 1996-02-21 1997-08-27 Jürgen A. Dr. Richt Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
KR0177890B1 (ko) * 1996-03-05 1999-04-01 이병언 반응특이성이 향상된 중합효소 연쇄반응용 튜브
ES2185002T3 (es) 1996-03-20 2003-04-16 Us Gov Health & Human Serv Metodos y composiciones para detectar mutaciones por empalme de la deshidrogenasa de dihidro-pirimidina.
WO1997043407A1 (en) 1996-05-10 1997-11-20 Phylomed Corporation Methods for oxidizing disulfide bonds using ozone
US5968737A (en) * 1996-11-12 1999-10-19 The University Of Mississippi Method of identifying inhibitors of glutathione S-transferase (GST) gene expression
EP0973935A2 (en) 1997-03-20 2000-01-26 Variagenics, Inc. Target genes for allele-specific drugs
US6248535B1 (en) 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
WO2002044423A2 (en) * 2000-12-01 2002-06-06 Response Genetics, Inc. Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors
US7618793B2 (en) * 2004-10-20 2009-11-17 The Regents Of The University Of Washington Identifying agents for decreasing cellular toxicity associated with huntingin polypeptide
US7618777B2 (en) * 2005-03-16 2009-11-17 Agilent Technologies, Inc. Composition and method for array hybridization
US7615729B2 (en) * 2007-12-10 2009-11-10 Aptina Imaging Corporation Apparatus and method for resonant lens focusing

Also Published As

Publication number Publication date
JP4308309B2 (ja) 2009-08-05
JP2004530434A (ja) 2004-10-07
US20050019783A1 (en) 2005-01-27
EP1407047A4 (en) 2005-03-30
US20020197609A1 (en) 2002-12-26
KR20090060380A (ko) 2009-06-11
IL159301A0 (en) 2004-06-01
EP1407047A1 (en) 2004-04-14
US6686155B2 (en) 2004-02-03
MXPA03011632A (es) 2005-04-19
NZ530520A (en) 2006-10-27
TWI338049B (en) 2011-03-01
IL159301A (en) 2010-06-16
CA2450257A1 (en) 2002-12-27
ES2457077T3 (es) 2014-04-24
KR20040018269A (ko) 2004-03-02
CN100494398C (zh) 2009-06-03
CN100355770C (zh) 2007-12-19
CA2450257C (en) 2012-11-06
CN1763064A (zh) 2006-04-26
WO2002103055A1 (en) 2002-12-27
AR034342A1 (es) 2004-02-18
US7138507B2 (en) 2006-11-21
US20040241705A1 (en) 2004-12-02
JP4303104B2 (ja) 2009-07-29
AU2002305573B2 (en) 2009-01-08
US20050074775A1 (en) 2005-04-07
EP1407047B1 (en) 2014-01-22
JP2009000118A (ja) 2009-01-08
CN1541277A (zh) 2004-10-27
KR100918927B1 (ko) 2009-09-28

Similar Documents

Publication Publication Date Title
HK1070921A1 (en) Method for determining the expression level of glutathione-s-transferase pi
IL156272A (en) Methods to determine gene expression level: 1ercc and use of a chemotherapy regimen selected using a drug preparation method
TW200628614A (en) Methods for determining a chemotherapeutic regimen comprising 5-fluorouracil, oxaliplatin, or combination thereof for treating a tumor in a patient
TW200833847A (en) Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival
WO2002070750A3 (en) Method of determining dihydropyrimidine dehydrogenase gene expression
Kim et al. S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy
WO2006085684A3 (en) Method of diagnosing bladder cancer
DE602004032556D1 (zh)
MXPA05005923A (es) Metodos para la identificacion, valoracion y tratamiento de pacientes con terapia para la inhibicion de la proteasoma.
WO2006015383A3 (en) Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity
WO2004111273A3 (en) Gene expression markers for response to egfr inhibitor drugs
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
MX2010005081A (es) Metodo para determinar la probabilidad de una respuesta terapeutica en la quimioterapia para el cancer con un glicosido cardiaco.
WO2007114896A3 (en) Prognostic and diagnostic method for cancer therapy
MX2010000405A (es) Seleccion de farmacos para terapia de cancer de pulmon usando arreglos a base de anticuerpos.
WO2006121991A3 (en) Compositions and methods for detection, prognosis and treatment of breast cancer
AU2012342397B2 (en) A method for predicting responsiveness to a treatment with an EGFR inhibitor
MXPA06014175A (es) Diagnostico o pronostico del curso del cancer de mama.
TW200643176A (en) ZNFN3A1/breast cancer related gene ZNFN3A1
MX2007007401A (es) Metodos para evaluar a pacientes con leucemia mieloide aguda.
WO2009082744A3 (en) Prognosis and interference-mediated treatment of breast cancer
Li Low expression of Mir-137 predicts poor prognosis in cutaneous melanoma patients
Jing et al. Down-expression of miR-373 predicts poor prognosis of glioma and could be a potential therapeutic target
Gallagher et al. p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors
Bhattacharya et al. Can interrogation of tumour characteristics lead us to safely omit adjuvant radiotherapy in patients with early breast cancer?

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190515